Skip to main content
OpenTrials
Completed

NCT Number: NCT02396979

Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia

The purpose of this study is to evaluate the relative impact a medical drug (methadone) or behavioral counseling program (Holistic Health Recovery Program) or both (methadone and Holistic Health Recovery Program) has on reducing HIV-related risk behaviors and illicit drug use among opioid-dependent, HIV-infected individuals in prison when given 90 to 180 days prior to leaving prison.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • HIV-infected
  • Clinical Diagnosis of Opioid Dependence
  • Fluent in Bahasa Malaysia or English
  • Within 90 to 180 days of release from prison
  • Planning to live in Klang Valley region after release from prison
  • Able to provide informed consent

Exclusion criteria

  • Pregnancy or planning to become pregnant (female only)

Treatment and study plan

Methadone

Drug

Holistic Health Recovery Program

Behavioral

Primary outcomes

  1. HIV Risk Events

    Time frame: Change from Baseline in HIV Risk Events at Months 3, 6, 9 and 12

    The primary outcome is the number of HIV high risk events. This outcome will be constructed from a composite measure counting the number of unprotected vaginal and anal insertive events and needle-or-syringe-sharing events with an HIV- or HIV-status-unknown partner that might result in HIV transmission to an uninfected partner. As such, the primary outcome will be the number of high-risk events during the period of observation in the intervention. All data will be self-reported by the participant.

Secondary outcomes

  1. HIV Quality of Life

    Time frame: Change from Baseline in HIV Quality of Life at Months 3, 6, 9 and 12

    This outcome will be measured by a series of questions that will be used to produce a composite score that will indicate the participant's overall quality of life as it relates to their HIV status. These questions will ask about your general health and your ability to perform daily activities in your life. All data will be self-reported by the participant.

  2. Relapse to Drug Use

    Time frame: Change from Baseline in Relapse to Drug Use at Months 3, 6, 9 and 12

    This outcome will be measured as any opioid drug use after release from prison. This outcome will be measured in two ways. First, participants will provide a monthly urine sample that will be tested for the presence of opioids. Second, participants will answer questions about their drug use since the time of their last interview.

  3. Addiction Severity

    Time frame: Change from Baseline in Addiction Severity at Months 3, 6, 9 and 12

    This outcome will be measured by a series of questions about the participant's drug use. These questions will be used to produce a composite score which indicates the severity of the participant's addiction.

  4. Reincarceration

    Time frame: Any reincarceration to prison during the 12 month post-release follow-up period

    This outcome will be measured by both self-report and objective data from the Malaysian Ministry of Prisons. Self-report questions will be used to ask participants if they have been arrested by police (placed in jail) or incarcerated in prison during the time since the last interview. Objective data will also be obtained from the Ministry of Prisons which will indicate if the participant has been reincarcerated in one of Malaysia's prison during the 12 months since they were initially released from prison.

Sponsors and collaborators

Lead sponsor

Yale University

Other

Collaborators

  • National Institute on Drug Abuse (NIDA)
  • University of Malaya

Registry information

Acronym: Harapan

Important dates

Study start
2010
Primary completion
2014
Study completion
2014
First posted
Mar 24, 2015
Registry last updated
Feb 26, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.